GO:0004677 DNA-dependent protein kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004677 DNA-dependent protein kinase activity describes the DNA-dependent phosphorylation of protein substrates using ATP, catalyzed primarily by the DNA-PK holoenzyme (DNA-PKcs plus Ku70/Ku80).
• DNA-PK is a serine/threonine kinase that is activated when Ku binds DNA ends and recruits DNA-PKcs, leading to autophosphorylation and substrate phosphorylation.
• Beyond classical non-homologous end joining (NHEJ), DNA-PKcs participates in telomere maintenance, transcription regulation, and RNA-processing-linked DNA repair.
• DNA-PK promotes DNA end processing through interactions with the MRN complex and CtIP, linking kinase activity to resection control.
• Dysregulated DNA-PK activity is implicated in cancer radioresistance and is being pursued as a therapeutic target with small-molecule inhibitors.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of DNA-PK subunit functions in repair, telomere biology, and disease.
Description
DNA-dependent protein kinase activity (GO:0004677) is a molecular function defined as DNA-dependent catalysis of the reaction ATP + a protein = ADP + a phosphoprotein. This activity is chiefly executed by the DNA-dependent protein kinase (DNA-PK) holoenzyme, a serine/threonine kinase complex composed of the catalytic subunit DNA-PKcs (PRKDC) and the Ku70/Ku80 heterodimer. The DNA dependence distinguishes it from many other kinases: efficient substrate phosphorylation requires the presence of DNA ends or specific DNA structures, which serve as assembly platforms for the enzyme. Because of this architecture, DNA-PK activity is a central node in the cellular response to DNA double-strand breaks (DSBs) and in non-homologous end joining (NHEJ). Researchers study GO:0004677 to understand how cells detect and repair DSBs, how repair choice is regulated, and how DNA-PK dysfunction contributes to cancer, radiosensitivity, and other pathologies. The kinase also has non-canonical roles in telomere maintenance and in RNA-binding-protein-mediated repair, making it relevant beyond classical DSB repair. In this article, we integrate the QuickGO definition with verified PubMed literature to outline the mechanism, key genes, disease links, and experimental models for studying DNA-dependent protein kinase activity.
DNA-dependent protein kinase activity At A Glance
| GO ID | GO:0004677 |
|---|---|
| GO term | DNA-dependent protein kinase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | DNA dependent catalysis of the reaction: ATP + a protein = ADP + a phosphoprotein |
| Major function | DNA-dependent phosphorylation of protein substrates, central to non-homologous end joining and DNA damage response |
| Primary enzyme complex | DNA-PK holoenzyme: DNA-PKcs (PRKDC) plus Ku70 (XRCC6)/Ku80 (XRCC5) heterodimer |
| Activation trigger | Binding of Ku to DNA ends and recruitment/autophosphorylation of DNA-PKcs |
| Representative substrates | DNA-PKcs itself (autophosphorylation), Ku70/Ku80, and other repair factors such as MRN/CtIP-associated proteins |
| Disease relevance | Cancer radioresistance, DNA repair deficiencies, and potential roles in telomere-related pathologies |
What Is GO:0004677?
GO:0004677 DNA-dependent protein kinase activity is a molecular function term describing the DNA-dependent transfer of a phosphate group from ATP to a protein substrate, yielding ADP and a phosphoprotein. In practice, this activity is measured as DNA-stimulated protein phosphorylation, most often associated with the DNA-PK holoenzyme (DNA-PKcs and Ku70/Ku80). The term captures the catalytic function rather than the broader biological process of DSB repair, although the activity is essential for NHEJ and related DNA transactions.
Why Is DNA-dependent protein kinase activity Important in Cell Biology?
DNA-dependent protein kinase activity is essential for maintaining genomic integrity because it initiates and regulates non-homologous end joining, the dominant DSB repair pathway in human cells. Loss or inhibition of this activity causes hypersensitivity to ionizing radiation and DSB-inducing agents, making it a key determinant of cancer therapy response. Beyond repair, DNA-PK activity influences telomere maintenance and RNA-binding-protein-mediated repair, linking it to aging and degenerative processes. Because the kinase is DNA-dependent, it provides a unique example of how nucleic acid scaffolds can control enzyme specificity and activation. Understanding GO:0004677 therefore informs basic mechanisms of genome stability, therapeutic targeting of DNA repair, and the design of CRISPR models to test gene function.
• Central to non-homologous end joining (NHEJ) and DSB repair, preserving genome stability.
• Required for cellular resistance to ionizing radiation and radiomimetic drugs.
• Regulates DNA end processing through MRN and CtIP interactions.
• Contributes to telomere maintenance and protection.
• Mediates YB-1-induced DSB repair, linking RNA-binding proteins to DNA repair.
• Activated by DNA ends via Ku-dependent recruitment and autophosphorylation.
• Targeted by small-molecule inhibitors to sensitize tumors to DNA-damaging therapy.
• Provides a paradigm for DNA-dependent enzyme regulation.
• Implicated in transcription and RNA processing beyond canonical repair.
• Enables CRISPR-based causal studies of repair, telomere, and disease phenotypes.
What Happens During DNA-dependent protein kinase activity?
DNA end recognition and Ku loading
In simple terms: The kinase first needs to find broken DNA ends, which is done by the Ku protein.
DNA-dependent protein kinase activity is initiated when the Ku70/Ku80 heterodimer binds DNA ends with high affinity. This binding is DNA-dependent and serves as the primary recruitment signal for the catalytic subunit DNA-PKcs. Ku loading onto DNA ends is a prerequisite for subsequent kinase activation and for NHEJ.
DNA-PKcs recruitment and holoenzyme assembly
In simple terms: Once Ku is on the DNA, it brings in the large kinase subunit to form the active enzyme.
Ku recruits DNA-PKcs to DNA ends, forming the DNA-PK holoenzyme. Structural and biochemical studies show that DNA-PKcs undergoes conformational changes upon DNA binding, which are required for activation. The assembled holoenzyme is the entity that catalyzes DNA-dependent protein phosphorylation.
Autophosphorylation and self-activation
In simple terms: The kinase phosphorylates itself to switch on its full activity.
DNA-PKcs autophosphorylation is a key step in its activation and regulation. Autophosphorylation occurs at multiple sites and can modulate kinase activity, DNA end processing, and repair factor recruitment. This self-activation mechanism ensures that kinase activity is tightly coupled to DNA damage.
Substrate phosphorylation and DNA end processing
In simple terms: The active kinase adds phosphates to other proteins, helping to prepare DNA ends for repair.
Activated DNA-PK phosphorylates protein substrates, including repair factors associated with the MRN complex and CtIP. DNA-PK activity promotes DNA end processing by MRN and CtIP, which is important for repair pathway choice and efficient NHEJ. This substrate phosphorylation links the kinase activity to downstream repair events.
Non-canonical roles in telomere and RNA-linked repair
In simple terms: The kinase also works at chromosome ends and with RNA-binding proteins.
DNA-PK activity contributes to telomere maintenance and protection, extending its functions beyond DSB repair. In addition, DNA-PK mediates YB-1-induced double-strand break repair, connecting RNA-binding proteins to DNA repair. These non-canonical roles highlight the broad biological impact of GO:0004677.
Key Genes Involved in GO:0004677 DNA-dependent protein kinase activity
The following genes and proteins are central to DNA-dependent protein kinase activity, its regulation, and its downstream repair functions.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKDC | Encodes DNA-PKcs, the catalytic subunit of DNA-PK | Core kinase for GO:0004677; knockout causes radiosensitivity and DSB repair defects |
| XRCC6 | Encodes Ku70, DNA end-binding subunit | Essential for Ku heterodimer formation and DNA-PK recruitment |
| XRCC5 | Encodes Ku80, DNA end-binding subunit | Required for DNA-PK holoenzyme assembly and NHEJ |
| XRCC4 | Non-homologous end joining factor | Downstream of DNA-PK in NHEJ; interacts with ligase IV |
| LIG4 | DNA ligase IV, seals DNA ends | Effector of NHEJ; functional link to DNA-PK activity |
| NHEJ1 | Encodes XLF/Cernunnos, NHEJ factor | Coordinates end joining with DNA-PK |
| MRE11 | Part of MRN complex, end processing | DNA-PK promotes MRN/CtIP-mediated end processing |
| RAD50 | Part of MRN complex | Interacts with DNA-PK during end processing |
| NBN | Encodes Nibrin, MRN component | Links DNA-PK activity to resection control |
| CtIP | End resection factor | DNA-PK regulates CtIP-dependent processing |
| YBX1 | RNA-binding protein YB-1 | Mediates YB-1-induced DSB repair via DNA-PK |
| TERF2 | Telomere protection factor | DNA-PK functions in telomere maintenance |
| TERF1 | Telomere repeat-binding factor | Telomere protection linked to DNA-PK |
| ATM | DNA damage response kinase | Pathway choice and crosstalk with DNA-PK |
| TP53 | Tumor suppressor, DNA damage response | DNA-PK activity influences p53-mediated outcomes |
| H2AFX | Histone H2AX, DNA damage marker | Phosphorylation marks DSBs and relates to DNA-PK function |
| PARP1 | Poly(ADP-ribose) polymerase | Crosstalk with DNA-PK in repair pathway choice |
| BRCA1 | Homologous recombination factor | Pathway choice between HR and NHEJ involving DNA-PK |
How Is DNA-dependent protein kinase activity Regulated?
DNA-dependent protein kinase activity is regulated at multiple levels. Activation requires DNA ends and Ku-mediated recruitment of DNA-PKcs, followed by autophosphorylation that modulates kinase activity. Autophosphorylation sites on DNA-PKcs can influence DNA end processing and repair factor recruitment, providing a self-regulatory mechanism. In addition, DNA-PK activity is coordinated with other DNA damage response kinases such as ATM, which can influence repair pathway choice. Non-canonical regulators include RNA-binding proteins like YB-1, which can stimulate DNA-PK-dependent DSB repair. Telomere-associated factors also modulate DNA-PK function at chromosome ends. Together, these layers ensure that kinase activity is spatially and temporally restricted to appropriate DNA substrates.
DNA-dependent protein kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKDC | Cancer radioresistance, DNA repair deficiency | PRKDC knockout or point-mutation cell lines; radiosensitivity assays |
| XRCC5 | NHEJ defect, radiosensitivity | XRCC5 knockout cells; Ku80 complementation |
| XRCC6 | NHEJ defect, genomic instability | XRCC6 knockout cells; Ku70 complementation |
| YBX1 | Vascular disease, YB-1-induced DSB repair | YBX1 overexpression or knockout in vascular cells |
| TERF2 | Telomere dysfunction, aging-related phenotypes | TERF2 knockout or tagged knock-in for telomere studies |
Cancer and radioresistance
DNA-PK activity is a major determinant of tumor cell resistance to ionizing radiation and DSB-inducing chemotherapies. High DNA-PKcs expression or activity can enhance NHEJ and promote survival after DNA damage, contributing to radioresistance. Consequently, DNA-PK inhibitors are being developed as radiosensitizers and chemosensitizers in cancer therapy. Preclinical studies show that targeting DNA-PK can increase sensitivity to DNA-damaging agents.
DNA repair deficiencies and genomic instability
Loss of DNA-PK activity causes defective NHEJ, leading to persistent DSBs, chromosomal aberrations, and hypersensitivity to radiation. Mutations in PRKDC or Ku subunits can impair DNA-PK holoenzyme assembly and function, resulting in genomic instability. Such defects are relevant to inherited and acquired disorders of DNA repair.
Telomere-related pathologies and aging
DNA-PK activity contributes to telomere maintenance and protection, and its dysfunction may affect telomere length regulation and chromosome end stability. Telomere dysfunction is linked to aging and degenerative phenotypes, suggesting that DNA-PK may influence these processes. However, the precise disease connections require further study.
RNA-binding protein-linked repair in vascular disease
YB-1-induced DSB repair is mediated by DNA-PK, linking RNA-binding proteins to DNA repair in vascular cells. This pathway may contribute to atherosclerosis-related biology, as suggested by studies in Arterioscler Thromb Vasc Biol. The finding expands the disease relevance of DNA-PK beyond classical cancer contexts.
From DNA-dependent protein kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is DNA-PKcs required for NHEJ and radioresistance? | PRKDC knockout cell line |
| How does Ku70/Ku80 DNA binding contribute to kinase activation? | XRCC6 or XRCC5 knockout with complementation |
| What is the role of DNA-PKcs autophosphorylation in repair? | Point-mutation knock-in of autophosphorylation sites |
| Does DNA-PK mediate YB-1-induced DSB repair? | YBX1 overexpression or knockout in vascular cells |
| How does DNA-PK function at telomeres? | Telomere factor knockout or tagged knock-in |
| Can DNA-PK inhibitors sensitize tumors to radiation? | Xenograft models with PRKDC wild-type and mutant cells |
How to Study the DNA-dependent protein kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | DNA-dependent phosphorylation of substrates | Testing DNA-PK activity and inhibitors |
| Autophosphorylation assay | DNA-PKcs self-phosphorylation | Studying activation mechanism |
| Gamma-H2AX foci | DSB formation and repair kinetics | Assessing repair defects in knockout cells |
| Comet assay | DNA strand breaks | Measuring radiosensitivity and repair capacity |
| Clonogenic survival | Cellular radiosensitivity | Evaluating DNA-PK inhibitor effects |
| Phosphoproteomics | Global phosphorylation changes | Identifying DNA-PK substrates |
| Cryo-EM | Structural conformation of DNA-PK holoenzyme | Understanding activation and assembly |
| Live-cell imaging | Recruitment dynamics of repair factors | Tracking DNA-PK complex at damage sites |
Kinase activity assays
DNA-dependent protein kinase activity is commonly measured using in vitro kinase assays with purified DNA-PK holoenzyme, DNA substrates, and ATP. These assays quantify phosphate incorporation into protein substrates and can be used to test inhibitors or mutations. Autophosphorylation can be assessed by autoradiography or phospho-specific antibodies.
DNA damage and repair assays
DSB repair capacity is evaluated using comet assays, gamma-H2AX foci, and reporter-based NHEJ assays. These methods link DNA-PK activity to functional repair outcomes. Radiosensitivity is measured by clonogenic survival after ionizing radiation.
Proteomics and phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies DNA-PK substrates and autophosphorylation sites. This approach reveals signaling networks downstream of GO:0004677. Quantitative phosphoproteomics can compare wild-type and mutant cells.
Imaging and structural approaches
Cryo-EM and X-ray crystallography have revealed DNA-PK holoenzyme architecture and activation-related conformational changes. Live-cell imaging of repair factors can track recruitment kinetics to DNA damage sites. These methods provide spatial and temporal resolution of DNA-PK function.
How CRISPR Can Be Used to Study GO:0004677 DNA-dependent protein kinase activity
Knockout
CRISPR knockout of PRKDC, XRCC6, or XRCC5 abolishes DNA-dependent protein kinase activity and causes defective NHEJ, radiosensitivity, and genomic instability. These models are used to test the requirement for DNA-PK in DSB repair and telomere maintenance. Knockout cells also serve as backgrounds for complementation with wild-type or mutant subunits.
Point Mutation
Point mutations in PRKDC autophosphorylation sites or kinase-domain residues can dissect activation and substrate specificity. CRISPR-mediated knock-in of these mutations allows study of DNA-PK function without losing the entire protein. Such models are valuable for separating kinase-dependent and scaffold functions.
Knock-in
Knock-in of epitope tags or fluorescent reporters into PRKDC, XRCC6, or XRCC5 enables imaging and proteomic analysis of the DNA-PK holoenzyme. Tagged knock-in models preserve endogenous regulation and can reveal real-time recruitment to DNA damage. These tools are useful for studying assembly and dynamics.
Overexpression
Overexpression of DNA-PKcs or Ku subunits can enhance NHEJ and increase radioresistance, modeling clinical scenarios of elevated DNA-PK activity. Such models help test whether increased DNA-PK activity is sufficient to drive resistance. Overexpression of YB-1 can also stimulate DNA-PK-dependent repair.
How EDITGENE Supports DNA-dependent protein kinase activity Research
Researchers studying DNA-dependent protein kinase activity-related genes often need to determine whether a candidate gene is causally involved in DNA repair, telomere maintenance, or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such causal studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for DNA-dependent protein kinase activity research.
Frequently Asked Questions About DNA-dependent protein kinase activity
What is DNA-dependent protein kinase activity?
It is a molecular function (GO:0004677) where a protein kinase phosphorylates substrates in a DNA-dependent manner, primarily catalyzed by the DNA-PK holoenzyme.
What genes are involved in DNA-dependent protein kinase activity?
Key genes include PRKDC (DNA-PKcs), XRCC6 (Ku70), XRCC5 (Ku80), and downstream NHEJ factors such as XRCC4 and LIG4.
How is DNA-dependent protein kinase activated?
Ku binds DNA ends, recruits DNA-PKcs, and autophosphorylation of DNA-PKcs leads to full activation.
What role does DNA-PK play in DNA repair?
DNA-PK is central to non-homologous end joining and promotes DNA end processing via MRN and CtIP.
Is DNA-PK involved in telomere maintenance?
Yes, DNA-PK contributes to telomere maintenance and protection.
Can DNA-PK be targeted for cancer therapy?
DNA-PK inhibitors are being developed to sensitize tumors to radiation and DNA-damaging drugs.
What diseases are linked to DNA-PK dysfunction?
Cancer radioresistance, DNA repair deficiencies, and telomere-related pathologies have been linked to DNA-PK dysfunction.
How do researchers measure DNA-dependent protein kinase activity?
In vitro kinase assays, autophosphorylation assays, and phosphoproteomics are commonly used.
What CRISPR models are used to study DNA-PK?
Knockout, point-mutation knock-in, tagged knock-in, and overexpression models of PRKDC, XRCC6, and XRCC5 are widely used.
Does DNA-PK interact with RNA-binding proteins?
Yes, DNA-PK mediates YB-1-induced double-strand break repair, linking RNA-binding proteins to DNA repair.
Conclusion
DNA-dependent protein kinase activity (GO:0004677) is a DNA-stimulated phosphorylation function executed by the DNA-PK holoenzyme, with essential roles in non-homologous end joining, DNA end processing, and telomere maintenance. Its dysregulation contributes to cancer radioresistance and genomic instability, making it a compelling therapeutic target. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide powerful tools to dissect the causal roles of DNA-PK subunits and substrates in health and disease. Continued research into this activity will advance both basic DNA repair biology and clinical strategies targeting DNA-PK.
References
- 1. Liang S et al.. 2023. Human DNA-dependent protein kinase activation mechanism.. Nat Struct Mol Biol 30(2):140-147 PMID: 36604499
- 2. Jackson SP. 1997. DNA-dependent protein kinase.. Int J Biochem Cell Biol 29(7):935-8 PMID: 9375373
- 3. Lee YR et al.. 2023. DNA-Dependent Protein Kinase Catalytic Subunit (DNA-PKcs): Beyond the DNA Double-Strand Break Repair.. Mol Cells 46(4):200-205 PMID: 36756777
- 4. Sui J et al.. 2020. DNA-dependent protein kinase in telomere maintenance and protection.. Cell Mol Biol Lett 25:2 PMID: 31988640
- 5. Nöthen T et al.. 2023. DNA-Dependent Protein Kinase Mediates YB-1 (Y-Box Binding Protein)-Induced Double Strand Break Repair.. Arterioscler Thromb Vasc Biol 43(2):300-311 PMID: 36475703
- 6. Kurosawa A. 2021. Autophosphorylation and Self-Activation of DNA-Dependent Protein Kinase.. Genes (Basel) 12(7) PMID: 34356107
- 7. Hui Z et al.. 2024. Development and therapeutic potential of DNA-dependent protein kinase inhibitors.. Bioorg Chem 150:107608 PMID: 38981210
- 8. Deshpande RA et al.. 2020. DNA-dependent protein kinase promotes DNA end processing by MRN and CtIP.. Sci Adv 6(2):eaay0922 PMID: 31934630
